Discovery of novel chiral diazepines as bombesin receptor subtype-3 (BRS-3) agonists with low brain penetration.
Matsufuji T, Shimada K, Kobayashi S, Kawamura A, Fujimoto T, Arita T, Hara T, Konishi M, Abe-Ohya R, Izumi M, Sogawa Y, Nagai Y, Yoshida K, Takahashi H.
Matsufuji T, et al. Among authors: izumi m.
Bioorg Med Chem Lett. 2014 Feb 1;24(3):750-5. doi: 10.1016/j.bmcl.2013.12.106. Epub 2014 Jan 2.
Bioorg Med Chem Lett. 2014.
PMID: 24412111